Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoya Shimokata

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
The Lancet. Oncology|May 30, 2014
Carboplatin plus paclitaxel scheduling for advanced ovarian cancerTomoya Shimokata, Yuichi Ando
The Lancet. Oncology|October 5, 2015
Discordance between the results and conclusions of ICON7Bishal Gyawali, Tomoya Shimokata, Yuichi Ando
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2016
Obvious Pitfall in the Estimation of Renal DysfunctionTomoya Shimokata, Yoshinari Yasuda, Yuichi Ando
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2020
5-FU, Irinotecan, Nab-Paclitaxel in Gastrointestinal Cancers-LetterOsamu Maeda, Tomoya Shimokata, Yuichi Ando
Nagoya Journal of Medical Science|August 19, 2014
Carboplatin dosing for adult Japanese patientsYuichi Ando, Tomoya Shimokata, Yoshinari Yasuda, et al.
Cancer Treatment Reviews|March 1, 2016
Chemotherapy in locally advanced head and neck squamous cell carcinomaBishal Gyawali, Tomoya Shimokata, Kazunori Honda, et al.
BMJ (Clinical Research Ed.)|November 3, 2018
Reporting harms more transparently in trials of cancer drugsBishal Gyawali, Tomoya Shimokata, Kazunori Honda, et al.
The Lancet. Oncology|July 4, 2014
Cancer care and research in India: what does it mean to Nepal?Bishal Gyawali, Bishesh Poudyal, Tomoya Shimokata, et al.
Cancer Causes & Control : CCC|September 30, 2016
Should low-income countries invest in breast cancer screening?Bishal Gyawali, Tomoya Shimokata, Kazunori Honda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Some questions on the randomized controlled trial of communication skills training for oncologistsBishal Gyawali, Hiroaki Tsukuura, Kazunori Honda, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
The Lancet. Oncology|May 30, 2014
Carboplatin plus paclitaxel scheduling for advanced ovarian cancerTomoya Shimokata, Yuichi Ando
The Lancet. Oncology|October 5, 2015
Discordance between the results and conclusions of ICON7Bishal Gyawali, Tomoya Shimokata, Yuichi Ando
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2016
Obvious Pitfall in the Estimation of Renal DysfunctionTomoya Shimokata, Yoshinari Yasuda, Yuichi Ando
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2020
5-FU, Irinotecan, Nab-Paclitaxel in Gastrointestinal Cancers-LetterOsamu Maeda, Tomoya Shimokata, Yuichi Ando
Nagoya Journal of Medical Science|August 19, 2014
Carboplatin dosing for adult Japanese patientsYuichi Ando, Tomoya Shimokata, Yoshinari Yasuda, et al.
Cancer Treatment Reviews|March 1, 2016
Chemotherapy in locally advanced head and neck squamous cell carcinomaBishal Gyawali, Tomoya Shimokata, Kazunori Honda, et al.
BMJ (Clinical Research Ed.)|November 3, 2018
Reporting harms more transparently in trials of cancer drugsBishal Gyawali, Tomoya Shimokata, Kazunori Honda, et al.
The Lancet. Oncology|July 4, 2014
Cancer care and research in India: what does it mean to Nepal?Bishal Gyawali, Bishesh Poudyal, Tomoya Shimokata, et al.
Cancer Causes & Control : CCC|September 30, 2016
Should low-income countries invest in breast cancer screening?Bishal Gyawali, Tomoya Shimokata, Kazunori Honda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Some questions on the randomized controlled trial of communication skills training for oncologistsBishal Gyawali, Hiroaki Tsukuura, Kazunori Honda, et al.
Pageof 6